111 related articles for article (PubMed ID: 12849704)
1. A Bcl-2 transgene expressed in hepatocytes does not protect mice from fulminant liver destruction induced by Fas ligand.
Loo Gv; Lippens S; Hahne M; Matthijssens F; Declercq W; Saelens X; Vandenabeele P
Cytokine; 2003 May; 22(3-4):62-70. PubMed ID: 12849704
[TBL] [Abstract][Full Text] [Related]
2. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA
Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950
[TBL] [Abstract][Full Text] [Related]
3. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).
Huang DC; Hahne M; Schroeter M; Frei K; Fontana A; Villunger A; Newton K; Tschopp J; Strasser A
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14871-6. PubMed ID: 10611305
[TBL] [Abstract][Full Text] [Related]
4. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
Baskin-Bey ES; Huang W; Ishimura N; Isomoto H; Bronk SF; Braley K; Craig RW; Moore DD; Gores GJ
Hepatology; 2006 Jul; 44(1):252-62. PubMed ID: 16799968
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor alpha protects against Fas-mediated liver apoptosis in mice.
Kanda D; Takagi H; Toyoda M; Horiguchi N; Nakajima H; Otsuka T; Mori M
FEBS Lett; 2002 May; 519(1-3):11-5. PubMed ID: 12023010
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1β enhances FasL-induced caspase-3/-7 activity without increasing apoptosis in primary mouse hepatocytes.
Lutz A; Sanwald J; Thomas M; Feuer R; Sawodny O; Ederer M; Borner C; Humar M; Merfort I
PLoS One; 2014; 9(12):e115603. PubMed ID: 25551609
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-XL.
Biswas RS; Cha HJ; Hardwick JM; Srivastava RK
Mol Cell Biochem; 2001 Sep; 225(1-):7-20. PubMed ID: 11716366
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
9. The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.
Schüngel S; Buitrago-Molina LE; Nalapareddy Pd; Lebofsky M; Manns MP; Jaeschke H; Gross A; Vogel A
Hepatology; 2009 Nov; 50(5):1558-66. PubMed ID: 19711425
[TBL] [Abstract][Full Text] [Related]
10. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection.
Rodriguez I; Matsuura K; Khatib K; Reed JC; Nagata S; Vassalli P
J Exp Med; 1996 Mar; 183(3):1031-6. PubMed ID: 8642244
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor α sensitizes primary murine hepatocytes to Fas/CD95-induced apoptosis in a Bim- and Bid-dependent manner.
Schmich K; Schlatter R; Corazza N; Sá Ferreira K; Ederer M; Brunner T; Borner C; Merfort I
Hepatology; 2011 Jan; 53(1):282-92. PubMed ID: 20872776
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
[TBL] [Abstract][Full Text] [Related]
13. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.
de la Coste A; Fabre M; McDonell N; Porteu A; Gilgenkrantz H; Perret C; Kahn A; Mignon A
Am J Physiol; 1999 Sep; 277(3):G702-8. PubMed ID: 10484397
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.
Lacronique V; Mignon A; Fabre M; Viollet B; Rouquet N; Molina T; Porteu A; Henrion A; Bouscary D; Varlet P; Joulin V; Kahn A
Nat Med; 1996 Jan; 2(1):80-6. PubMed ID: 8564847
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes.
Woo M; Hakem A; Elia AJ; Hakem R; Duncan GS; Patterson BJ; Mak TW
J Immunol; 1999 Nov; 163(9):4909-16. PubMed ID: 10528193
[TBL] [Abstract][Full Text] [Related]
16. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
[TBL] [Abstract][Full Text] [Related]
17. In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor.
Connolly K; Cho YH; Duan R; Fikes J; Gregorio T; LaFleur DW; Okoye Z; Salcedo TW; Santiago G; Ullrich S; Wei P; Windle K; Wong E; Yao XT; Zhang YQ; Zheng G; Moore PA
J Pharmacol Exp Ther; 2001 Jul; 298(1):25-33. PubMed ID: 11408521
[TBL] [Abstract][Full Text] [Related]
18. Fas-induced apoptosis in mouse hepatocytes is dependent on C/EBPbeta.
Mukherjee D; Kaestner KH; Kovalovich KK; Greenbaum LE
Hepatology; 2001 May; 33(5):1166-72. PubMed ID: 11343245
[TBL] [Abstract][Full Text] [Related]
19. Protective role of interleukin-18 against Fas-mediated liver injury.
Yamamoto N; Murata K; Yoneda K; Fuke H; Yamaguchi Y; Ito K; Sugimoto K; Shiraki K; Yamanaka K; Mizutani H; Takei Y
Int J Mol Med; 2008 Jul; 22(1):43-8. PubMed ID: 18575774
[TBL] [Abstract][Full Text] [Related]
20. Hypothermia inhibits Fas-mediated apoptosis of primary mouse hepatocytes in culture.
Fu T; Blei AT; Takamura N; Lin T; Guo D; Li H; O'Gorman MR; Soriano HE
Cell Transplant; 2004; 13(6):667-76. PubMed ID: 15648737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
